TAT-NBD

General Information


DRACP ID  DRACP05667

Peptide Name   TAT-NBD

Sequence  YGRKKRRQRRRGTALDWSWLQTE

Sequence Length  23

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C128H207N47O34

Absent amino acids  CFHIMNPV

Common amino acids  R

Mass  334092

Pl  12.22

Basic residues  8

Acidic residues  2

Hydrophobic residues  5

Net charge  6

Boman Index  -11772

Hydrophobicity  -197.83

Aliphatic Index  38.26

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  12490

Absorbance 280nm  567.73

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22580115

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2713

DRACP is developed by Dr.Zheng's team.